Learn to Quit-HIV Pilot Study

• Status: Recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Duke University
• Collaborator: National Institutes of Health (NIH)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• HIV-positive

• Currently engaged with an HIV care provider

• Self-report smoking 5 cigarettes or more per day during the past 30 days

• Age 18 years or older

• Current interest in quitting smoking

• Currently own a functioning Android or Apple smartphone

Exclusion Criteria:

• No desire to quit smoking

• Inability to attend study sessions

• Inability to provide informed consent

• Any medical condition or concomitant medication that could compromise subject safety or treatment, as determined by the Principal Investigators and/or Study Physician

• Presence of contraindications for nicotine patch

• Previous allergic reaction or hypersensitivity to nicotine patch (lifetime)

• Current use of nicotine replacement therapy or other smoking cessation treatment (e.g., bupropion, varenicline)

• Pregnant, planning to become pregnant, nursing, or becoming pregnant during the study

• Current untreated and unstable diagnosis of alcohol/substance abuse or dependence (eligible if past abuse/dependence and if receiving treatment and stable for >30 days)